DANCAN Share Price Performance
DKK 0.30
-1.90 (-86.36%)
Price DKK 0.30
Share Pricen/a
DanCann Pharma A/S Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
DANCAN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
DanCann Pharma A/S Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -2.50
- -76.76%
- -248.89%
- 0%
About DANCAN
- Founded
- 2018
- Employees
- 5
- CEO
- WebsiteView website
DanCann Pharma A/S, a biopharmaceutical company, focuses on commercializing new therapeutic cannabinoids in various disease areas. The company distributes prescription cannabinoid-based medicines. It develops EXT03 CannGros, an oral extract based on Bediol; EXT04 CannGros, an oral extract based on Bedrolite; EXT02 CannGros, an oral extract based on Bedrocan; FLS04 CannGros granulate; FLS05 CannGros flos; and OTC01 CannGros, OTC02 CannGros, and OTC03 CannGros extracts. The company was incorporated in 2018 and is based in Ansager, Denmark.
